DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Srinivasan J, Richens A.
A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.
Drug Saf 1994; 10: 395-405
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.